Francesco Messina

7PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsInnate immunityHumoural immunology and immunochemistryGene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|Mar 25, 2022
Trauma of Peripheral Innervation Impairs Content of Epidermal Langerhans Cells.

Giovanna Albertin, Barbara Ravara, Helmut Kern

|Dec 21, 2021
Efficacy and safety of guselkumab in two psoriatic patients with hepatitis B and C virus infection.

Francesco Messina, Francesca Peccerillo, Giulia Odorici

|May 11, 2021
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis.

Stefano Piaserico, Andrea Conti, Francesco Messina

|May 06, 2021
Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues.

Martina Ferranti, Giulia Tadiotto Cicogna, Francesco Messina

|Aug 21, 2020
Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'.

Francesco Messina, Francesca Pampaloni, Stefano Piaserico

Pageof 2

Frequent Collaborators

3 joint publications

Stefano Piaserico

2 joint publications

Andrea Conti

2 joint publications

Giulia Odorici

2 joint publications

Paolo Gisondi